|
|
Volumn 6, Issue 5, 2010, Pages 246-
|
|
In brief
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD20 ANTIBODY;
ENZYME ANTIBODY;
GLUCOSE 6 PHOSPHATE ISOMERASE;
RITUXIMAB;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIBODY TITER;
ANTIGEN EXPRESSION;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
ARTIFICIAL CHROMOSOME;
AUTOIMMUNITY;
B LYMPHOCYTE;
BLOOD CELL;
BONE MARROW CELL;
CELL COUNT;
CELL DIFFERENTIATION;
CELL TYPE;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SENSITIVITY;
DRUG TARGETING;
HUMORAL IMMUNE DEFICIENCY;
IMMUNOGLOBULIN PRODUCING CELL;
LYMPH NODE CELL;
MOUSE;
NONHUMAN;
PERITONEUM CELL;
PLASMA CELL;
PLASMABLAST;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
RHEUMATOID ARTHRITIS;
SPLEEN CELL;
TRANSGENE;
TREATMENT OUTCOME;
TURNOVER TIME;
|
|
EID: 77951968399
PISSN: 17594790
EISSN: 17594804
Source Type: Journal
DOI: 10.1038/nrrheum.2010.53 Document Type: Article |
|
Times cited : (3)
|
|
References (1)
|
